Business / Finance

RSS

FEI announces the sale of a complete correlative workflow to the University of Maastricht

FEI (NASDAQ: FEIC) announces the sale of a complete correlative workflow to the University of Maastricht. The systems will be installed at the University’s Institute of Nanoscopy, a new research facility that will use the high-resolution microscopes to understand the working mechanisms of protein complexes in an effort to develop new and improved treatment and prevention for disease, such as cancer and tuberculosis.

23 Jun 2014

Dimension Therapeutics closes $30M financing to advance novel gene therapy programs

Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the closing of a $30 million financing.

23 Jun 2014

Definiens closes €15M financing round to expand into digital tissue diagnostics

Definiens AG, which offers a unique approach to tissue diagnostics aimed at helping physicians improve treatment, said that it has closed a round of financing for € 15 million.

23 Jun 2014

Premier PHC, Encompass partner to improve patient outcomes

Premier Patient Health Care and Encompass Home Health & Hospice are pleased to announce a new partnership that actively manages the quality and cost of care for patients across multiple settings, in order to meet quality benchmarks and improve patient outcomes.

21 Jun 2014

Celsion acquires all assets of EGEN

Celsion Corporation, an oncology drug development company, today announced the completion of the acquisition by Celsion of substantially all of the assets of EGEN, Inc., a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases.

21 Jun 2014

Neovasc's common shares to commence trading on TSX

Neovasc Inc. ("Neovasc" or the "Company") today announced that effective at market opening on June 23, 2014, Neovasc's common shares will commence trading on the Toronto Stock Exchange (the "TSX") under the Company's current trading symbol of "NVC".

20 Jun 2014

Merck commences cash tender offer to purchase Idenix Pharmaceuticals

Merck, known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals, Inc. On June 09, 2014, Merck announced its intent to acquire Idenix.

20 Jun 2014

Peakdale Molecular reports significant growth in demand for its medicinal chemistry services

Peakdale Molecular, a leading UK provider of medicinal chemistry and chemistry services, is celebrating its most successful year ever for revenues and earnings since the company’s inception in 1992.

19 Jun 2014

Agfa HealthCare Corp. and OnBase by Hyland integrate best-in-class enterprise imaging and enterprise content management technologies to optimize the EHR

Agfa HealthCare Corp. announced today a new collaboration with OnBase to integrate the "gold standards" in enterprise imaging and enterprise content management technologies to showcase the vast potential of a fully integrated, "document + image" electronic health record (EHR).

19 Jun 2014

Electroanalysis journal publishes a special issue about clinical diagnostics

The demand for the development of novel diagnostic tools with interest for clinical analysis is increasing.

19 Jun 2014

Electroanalysis journal publishes a special issue about clinical diagnostics

The demand for the development of novel diagnostic tools with interest for clinical analysis is increasing.

19 Jun 2014

Five Points Healthcare announces acquisition of BestCare Home Care

Five Points Healthcare announced that it acquired BestCare Home Care on April 30, 2014. BestCare is a home health provider of Medicare-certified, Medicaid-waiver and personal care services throughout Northern and Western Virginia.

18 Jun 2014

Medison to market uniQure's Glybera in Israel for treatment of lipoprotein lipase deficiency

uniQure N.V., a leader in human gene therapy, and Medison Pharma Ltd., Israel's leading international healthcare marketing group, today announced an exclusive distribution agreement under which Medison will market Glybera, uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency (LPLD), in Israel and the Palestinian Authority.

18 Jun 2014

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.

18 Jun 2014

LABORIE completes acquisition of BUCK Elektromedizin and BUCKmeditec

Laborie Medical Technologies, Inc., based in Toronto, Ontario, has completed its acquisition of BUCK Elektromedizin GmbH and BUCKmeditec GmbH & Co. Bad Rappenaeau, Germany based BUCK develops and distributes innovative and advanced biofeedback and electrical stimulation equipment, accessories and consumables for pelvic floor dysfunction in the treatment of urinary and fecal incontinence.

18 Jun 2014

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with Selecta Biosciences for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis.

18 Jun 2014

Western Oncolytics closes $275,000 in seed funding

Western Oncolytics Ltd., a biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. The proceeds are planned to set a path toward clinical trials and execute initial manufacturing for its novel virus-based cancer therapy, which delivers genes to guide the immune system to kill cancer cells.

18 Jun 2014

Saint-Gobain Seals continues its long-standing relationship with OEMs

Saint-Gobain Seals continues its long-standing relationship with OEMs in the high-speed surgical drill market as their integral supplier of OmniSeal® spring-energized seals. The seals excel at protecting the sensitive internal components of the drill during surgery and sterilization, ensuring a long life of the tool.

17 Jun 2014

Distribution partnership announced by Nanion Technologies and Axion Biosystems

Nanion Technologies, a leading provider of automated patch clamp platforms, and Axion Biosystems, originator of the first high throughput microelectrode array system, today announce a distribution partnership in Europe and China. Nanion will immediately carry Axion’s MEA-products, supporting a broad range of biomedical applications.

17 Jun 2014

BioClinica announces acquisition of Blueprint Clinical to drive RBM strategies for clinical trials

BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.

From Clario 16 Jun 2014

Business / Finance

FEI announces the sale of a complete correlative workflow to the University of Maastricht

Dimension Therapeutics closes $30M financing to advance novel gene therapy programs

Definiens closes €15M financing round to expand into digital tissue diagnostics

Premier PHC, Encompass partner to improve patient outcomes

Celsion acquires all assets of EGEN

Neovasc's common shares to commence trading on TSX

Merck commences cash tender offer to purchase Idenix Pharmaceuticals

Peakdale Molecular reports significant growth in demand for its medicinal chemistry services

Agfa HealthCare Corp. and OnBase by Hyland integrate best-in-class enterprise imaging and enterprise content management technologies to optimize the EHR

Electroanalysis journal publishes a special issue about clinical diagnostics

Electroanalysis journal publishes a special issue about clinical diagnostics

Five Points Healthcare announces acquisition of BestCare Home Care

Medison to market uniQure's Glybera in Israel for treatment of lipoprotein lipase deficiency

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

LABORIE completes acquisition of BUCK Elektromedizin and BUCKmeditec

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

Western Oncolytics closes $275,000 in seed funding

Saint-Gobain Seals continues its long-standing relationship with OEMs

Distribution partnership announced by Nanion Technologies and Axion Biosystems

BioClinica announces acquisition of Blueprint Clinical to drive RBM strategies for clinical trials

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News